Dental patients who have had dermal fillers for cosmetic or corrective surgery could experience inflammation after a procedure according to the FDA.
The US Food and Drug Administration recently updated its page on dermal fillers to include a warning that people with soft tissue fillers may experience inflammation or swelling after a dental procedure.
Specifically, the FDA noted that swelling or redness may develop near the dermal filler injection site following viral or bacterial illnesses or infections, vaccinations, or dental procedures.
The new note was included under the less common risks section of the FDA’s information page on dermal fillers, meaning that it was far from a certainty that it could occur.
The FDA approves soft tissue fillers for use in treating wrinkles, augmenting lips, cheeks and certain other parts of the body, as well as for certain corrective procedures.